Concurrent hyperfractionated radiation therapy and low dose, daily chemotherapy as an effective and low toxicity approach in locally advanced (stage III) non-small-cell lung cancer

Clinical Lung Cancer

Volumn 15, Issue 3, 2014, Pages

  Jeremić, Branislav ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL RESEARCH; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; ONCOLOGIST; RADIATION DOSE; SURVIVAL TIME; CHEMORADIOTHERAPY; COMPLICATION; HEMATOLOGIC DISEASES; LUNG TUMOR; NON SMALL CELL LUNG CANCER; RADIATION INJURIES;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; HEMATOLOGIC DISEASES; HUMANS; LUNG NEOPLASMS; RADIATION INJURIES;

EID: 84897970566     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.09.006     Document Type: Letter

References (8)

1. C.C. Koning, S.J. Wouterse, J.G. Daams, L.L. Uitterhoeve, M.M. van den Heuvel, and J.S. Belderbos Toxicity of concurrent radiochemotherapy for locally advanced non-small-cell lung cancer: a systematic review of the literature Clin Lung Cancer 14 2013 481 487
2. H. Bartelink, R.F. Kallman, D. Rapacchietta, and G.A. Hart Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation Radiother Oncol 6 1986 61 74 (Pubitemid 16038441)
3. C. Schaake-Koning, W. van den Bogaert, and O. Dalesio et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530
4. B. Jeremic, Y. Shibamoto, and L.J. Acimovic et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer J Clin Oncol 13 1995 452 458
5. B. Jeremic, Y. Shibamoto, and L.J. Acimovic et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for stage III non-small-cell lung cancer: a randomized study J Clin Oncol 14 1996 1065 1070 (Pubitemid 26105510)
6. B. Jeremic, Y. Shibamoto, and B. Milicic et al. Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC). Long-term results of a phase II study Int J Radiat Oncol Biol Phys 42 1998 1091 1096 (Pubitemid 29004153)
7. B. Jeremic, Y. Shibamoto, and L.J. Acimovic et al. Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without week-end carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial Int J Radiat Oncol Biol Phys 50 2001 19 25
8. B. Jeremic, B. Milicic, and L.J. Acimovic et al. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with stage III non-small-cell lung cancer (NSCLC). Long-term results of a phase II study J Clin Oncol 23 2005 1144 1151 (Pubitemid 46202270)